ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 371 • 2017 ACR/ARHP Annual Meeting

    Longer Term Outcomes of Chronic Relapsing Multifocal Osteomyelitis in a UK Tertiary Adolescent and Young Adult Rheumatology Centre

    Kristina E.N. Clark1, Francesca Josephs2, Nicola Daly3, Claire Louise Murphy3 and Debajit Sen4, 1Rheumatology, University college London Hospitals, London, United Kingdom, 2rhuematology, UCL, London, United Kingdom, 3Rheumatology, University College London Hospital, London, United Kingdom, 4Adolescent Rheumatology Department, University College London Hospital NHS Trust, London, United Kingdom

    Background/Purpose: Chronic relapsing multifocal osteomyelitis (CRMO) is a rare autoinflammatory bone condition presenting primarily in children & adolescents. It characteristically affects the epiphysis & metaphysis…
  • Abstract Number: 372 • 2017 ACR/ARHP Annual Meeting

    Phenotype of Chronic Recurrent Multifocal Osteomyelitis in a Tertiary Referral Centre: The Great Ormond Street Hospital Experience

    Kulsoom Riaz1 and Sandrine Lacassagne2, 1Paediatric Rheumatology/Gastroenterology, Great Ormond Street Hospital, London, United Kingdom, 2Paediatric Rheumatology, Great Ormond Street Hospital, London, United Kingdom

    Background/Purpose: Recurrent Multifocal Osteomyelitis (CRMO) is an aseptic inflammatory bone disease that typically affects the metaphases of the long bones. It affects children, adolescents and…
  • Abstract Number: 373 • 2017 ACR/ARHP Annual Meeting

    a Retrospective Study of Clinical Factors Influencing the Development of Overlapping Disease Features in Pediatric Patients with Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Spondyloarthropathies (SpA)

    Lillian Lim1, Jyoti Panwar2, Jennifer Stimec3, Shirley M.L. Tse4, Brian M. Feldman5 and Ronald M. Laxer6, 1Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada, 2Christian Medical College, Vellore, India, Vellore, India, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 5Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 6Div of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Some studies have suggested that chronic recurrent multifocal osteomyelitis (CRMO) and spondyloarthropathies (SpA) fall on a spectrum of disease, as they have been noted…
  • Abstract Number: 374 • 2017 ACR/ARHP Annual Meeting

    A Pilot Study of Infrared Thermal Imaging to Detect Active Bone Lesions in Children with Chronic Nonbacterial Osteomyelitis

    Yongdong Zhao1, Ramesh Iyer2, Lucas Reichley1, Assaf Oron3, Averi Kitsch4, Seth Friedman5, Savannah Partridge4 and Carol A Wallace1, 1University of Washington, Department of Pediatrics, Seattle, WA, 2Division of Radiology, University of Washington, Seattle Children’s Hospital, Seattle, WA, 3Center for Clinical and Translational Research, Seattle Children’s Research Institute, Seattle, WA, 4Department of Radiology, University of Washington, Seattle, WA, 5Division of Radiology, University of Washington, Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease. For detection of active bone lesions, bone scintigraphy and magnetic resonance imaging (MRI) are much…
  • Abstract Number: 375 • 2017 ACR/ARHP Annual Meeting

    Controlled Discontinuation of  Colchicine Therapy in  Familial  Mediterranean Fever Patients with Single MEFV Mutation

    Yonatan Butbul Aviel1, Shafe Fahoum2 and Riva Brik3, 1Department of Pediatrics B Pediatric Rheumatology Service, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel, Haifa, Israel, 2Department of Pediatrics B,, , Ruth Children's Hospital, Rambam Medical Center, Haifa, Israel, Pediatric Rheumatology Service, .Rappaport Faculty of Medicine, Technion-lsrael Institute of Technology, Haifa, Israel, 3Pediatrics, Rambam Medical Center, Haifa, Israel

    Background/Purpose: Familial Mediterranean fever (FMF) traditionally has been considered an autosomal recessive disease; however, the diagnosis remains predominantly clinical, since mutations cannot always be identified…
  • Abstract Number: 376 • 2017 ACR/ARHP Annual Meeting

    Improvement of Disease Activity in Patients with Colchicine-Resistant FMF, Hids/Mkd and TRAPS Assessed By Autoinflammatory Disease Activity Index (AIDAI): Results from a Randomized Phase III Trial

    Isabelle Koné-Paut1, Michaël Hofer2, Susanne Benseler3, Jasmin B. Kuemmerle-Deschner4, Annette Jansson5, Itzhak Rosner6, Raffaele Manna7, Sara Murias8, Omer Karadag9, Lori Tucker10, Ilonka Orban11, Vincent Tormey12, Maria Alessio13, Huri Ozdogan14 and Fabrizio De Benedetti15, 1Bicêtre Hospital, APHP, Univeristy Paris Sud, Paris, France, 2Unité romande d’immuno-rhumatologie pédiatrique, CHUV, University of Lausanne, Genova, Italy, 3Alberta Children's Hospital, Calgary, AB, Canada, 4University Hospital Tuebingen, Tuebingen, Germany, 5Ludwig Maximilian University, Munich, Germany, 6Bnai-Zion Medical Center, Haifa, Israel, 7Department of Internal Medicine, Università Cattolica Sacro Cuore, Rome, Italy, 8Hospital Infantil La Paz, Madrid, Spain, 9Hacettepe University Faculty of Medicine, Ankara, Turkey, 10BC Children's Hospital, Vancouver, BC, Canada, 11Orszagos Reumatologial es Fizioterepias, Budapest, Hungary, 12University College Hospital Galway, Galway, Ireland, 13A Osped-Universit Policlinico Federico II, Univ degli Studi di Napoli, Napoli, Italy, 14Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Division of Rheumatology, Istanbul, Turkey, 15Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, Genoa, Italy

    Background/Purpose: AIDAI is a novel, validated tool for the assessment of disease activity across a wide spectrum of autoinflammatory diseases including recurrent fever syndromes such…
  • Abstract Number: 377 • 2017 ACR/ARHP Annual Meeting

    Novel Insights into Periodic Fever Syndromes

    Tiffany Hoang1, Shreya Shrestha1 and Daniel Albert2, 1Dartmouth Medical School, Lebanon, NH, 2Medicine/Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH

    Background/Purpose: The Periodic Fever Syndromes (PFS) are a rapidly expanding group of disorders primarily of the innate immune system that often affect the inflammasome. In…
  • Abstract Number: 378 • 2017 ACR/ARHP Annual Meeting

    Musculoskeletal Features in Copa Syndrome

    William B. Lapin1, Monica Marcus2, Andrea A. Ramirez3, Marietta M. de Guzman3 and Levi B. Watkin4,5, 1Department of Pediatrics, Division of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2Pediatric Immunology, Allergy and Rheumatology, Texas Children's Hospital, Houston, TX, 3Immunology, Allergy and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 4Department of Pediatrics, Division of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, TX, 5Texas Children's Hospital, Center for Human Immunobiology, Houston, TX

    Background/Purpose: COPA syndrome is a newly discovered primary immunodeficiency resulting in immune dysregulation showing autosomal dominant inheritance with incomplete penetrance. Its name is derived from…
  • Abstract Number: 379 • 2017 ACR/ARHP Annual Meeting

    H Syndrome: Five New Cases from the United States with Novel Features and Responses to Therapy

    Jessica Bloom1, Clara Lin2, Lisa F. Imundo3, Stephen Guthery4, Shelly Stepenaskie5, Csaba Galambos6, Amy Lowichik7 and John F. Bohnsack8, 1Pediatrics, Children's Hospital Colorado, Aurora, CO, 2Pediatric Rheumatology, Children's Hospital Colorado, Aurora, CO, 3Pediatrics, Columbia University Medical Center, New York, NY, 4Department of Pediatrics,, University of Utah, Salt Lake City, UT, 5Pathology and Dermatology, University of New Mexico, Albuquerque, NM, 6Pathology, Children's Hospital Colorado, Aurora, CO, 7Pathology, University of Utah, Salt Lake City, UT, 8Division of Allergy, Immunology and Pediatric Rheumatology, University of Utah, Salt Lake City, UT

    Background/Purpose: H Syndrome is an autosomal recessive disorder characterized by cutaneous hyperpigmentation, hypertrichosis, and induration with numerous systemic manifestations. The syndrome is caused by mutations…
  • Abstract Number: 380 • 2017 ACR/ARHP Annual Meeting

    Treatment Outcomes of Down Syndrome Arthropathy

    Jordan T. Jones1, Leena Danawala2, Nasreen Talib3 and Mara L Becker4, 1Rheumatology Division, Children's Mercy Kansas City, Kansas City, MO, 2University of Missouri-Kansas City School of Medicine, Kansas City, MO, 3General Pediatrics, Children's Mercy Kansas City, Kansas City, MO, 4Rheumatology, Children's Mercy Kansas City, Kansas City, MO

    Background/Purpose: Crude prevalence estimates indicate Down syndrome arthropathy (DA) is 3-8 times more common than juvenile idiopathic arthritis (JIA), however, DA is still largely under…
  • Abstract Number: 381 • 2017 ACR/ARHP Annual Meeting

    Down’s Arthritis (DA) – Clinical and Radiological Features of Arthritis in Children with Trisomy 21

    Charlene Foley, Emma Jane Mac Dermott and Orla Killeen, National Centre for Paediatric Rheumatology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland

    Background/Purpose: Down's Arthritis (DA) was first reported in the literature in 1984. Crude estimates suggest higher incidence and prevalence rates of DA compared with Juvenile…
  • Abstract Number: 382 • 2017 ACR/ARHP Annual Meeting

    Radiological Features Identified in the Hands of Children with Down Syndrome and Inflammatory Arthritis

    Charlene Foley1, Emma Jane Mac Dermott1, Aisling Snow2 and Orla G Killeen1, 1National Centre for Paediatric Rheumatology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland, 2Radiology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland

    Background/Purpose: Down’s Arthritis (DA) is an inflammatory joint condition affecting children with Down syndrome (DS). It is 18-21 times more common than JIA in the…
  • Abstract Number: 383 • 2017 ACR/ARHP Annual Meeting

    Immunogenicity of 13 Valent Pneumococcal Vaccine in Children with Lupus: Single Center Experience in South Texas

    Elissa Gonzalez, Joe Cole and Mark Gorelik, Pediatrics, Baylor College of Medicine/Children's Hospital of San Antonio, San Antonio, TX

    Background/Purpose: Pneumococcal vaccination is an important part of the care of pediatric and adult patients with systemic lupus erythematosus, and is recommended as a quality…
  • Abstract Number: 384 • 2017 ACR/ARHP Annual Meeting

    Protection Against Hepatitis B in Immunocompromised Pediatric Rheumatology and Gastroenterology Patients

    Najla Aljaberi1, Emily A. Smitherman2, Enas Ghulam3, Allen Watts2, Dana MH Dykes4 and Jennifer L. Huggins5, 1Pediatric rheumatology, Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Environmental health and biostatistics, Department of Environmental Health, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 4Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Hepatitis B infection remains a significant public health challenge, particularly for patients on chronic immunosuppressive therapy, due to a considerable mortality risk associated with…
  • Abstract Number: 385 • 2017 ACR/ARHP Annual Meeting

    Reliable Implementation of a Hepatitis B Serology Screening and Vaccination Process for Immunocompromised Pediatric Rheumatology Patients

    Emily A. Smitherman1, Adam Furnier2, Allen Watts1, Sandra Kramer1, Elizabeth Joy Baker1, Dana MH Dykes3, Rebecca Brady4 and Jennifer L. Huggins5, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Vaccine-preventable infections, including reactivation of hepatitis B virus, are a leading cause of morbidity and mortality in immunocompromised patients. Guidelines recommend that all immunosuppressed…
  • « Previous Page
  • 1
  • …
  • 1410
  • 1411
  • 1412
  • 1413
  • 1414
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology